These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

921 related articles for article (PubMed ID: 25604277)

  • 1. Azithromycin and ciprofloxacin: a possible synergistic combination against Pseudomonas aeruginosa biofilm-associated urinary tract infections.
    Saini H; Chhibber S; Harjai K
    Int J Antimicrob Agents; 2015 Apr; 45(4):359-67. PubMed ID: 25604277
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Azithromycin-Ciprofloxacin-Impregnated Urinary Catheters Avert Bacterial Colonization, Biofilm Formation, and Inflammation in a Murine Model of Foreign-Body-Associated Urinary Tract Infections Caused by Pseudomonas aeruginosa.
    Saini H; Vadekeetil A; Chhibber S; Harjai K
    Antimicrob Agents Chemother; 2017 Mar; 61(3):. PubMed ID: 28031194
    [No Abstract]   [Full Text] [Related]  

  • 3. Inhibition of quorum sensing in Pseudomonas aeruginosa by azithromycin and its effectiveness in urinary tract infections.
    Bala A; Kumar R; Harjai K
    J Med Microbiol; 2011 Mar; 60(Pt 3):300-306. PubMed ID: 21127154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of Combined Ciprofloxacin and azithromycin free and nano formulations to control biofilm producing Pseudomonas aeruginosa isolated from burn wounds.
    Raouf M; Essa S; El Achy S; Essawy M; Rafik S; Baddour M
    Indian J Med Microbiol; 2021 Jan; 39(1):81-87. PubMed ID: 33460732
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synergistic Activity of Berberine with Azithromycin against Pseudomonas Aeruginosa Isolated from Patients with Cystic Fibrosis of Lung In Vitro and In Vivo.
    Li Y; Huang J; Li L; Liu L
    Cell Physiol Biochem; 2017; 42(4):1657-1669. PubMed ID: 28738346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of ciprofloxacin-clarithromycin combination against drug-resistant Pseudomonas aeruginosa mature biofilm using in vitro experimental model.
    Elkhatib W; Noreddin A
    Microb Drug Resist; 2014 Dec; 20(6):575-82. PubMed ID: 25050970
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Azithromycin retards Pseudomonas aeruginosa biofilm formation.
    Gillis RJ; Iglewski BH
    J Clin Microbiol; 2004 Dec; 42(12):5842-5. PubMed ID: 15583321
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pseudomonas quinolone signalling system: a component of quorum sensing cascade is a crucial player in the acute urinary tract infection caused by Pseudomonas aeruginosa.
    Bala A; Chhibber S; Harjai K
    Int J Med Microbiol; 2014 Nov; 304(8):1199-208. PubMed ID: 25240873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exploiting the antivirulence efficacy of an ajoene-ciprofloxacin combination against Pseudomonas aeruginosa biofilm associated murine acute pyelonephritis.
    Vadekeetil A; Saini H; Chhibber S; Harjai K
    Biofouling; 2016; 32(4):371-82. PubMed ID: 26930141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of Pseudomonas aeruginosa biofilms with a combination of fluoroquinolones and fosfomycin in a rat urinary tract infection model.
    Mikuniya T; Kato Y; Ida T; Maebashi K; Monden K; Kariyama R; Kumon H
    J Infect Chemother; 2007 Oct; 13(5):285-90. PubMed ID: 17982715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased therapeutic efficacy of combination of azithromycin and ceftazidime on Pseudomonas aeruginosa biofilm in an animal model of ureteral stent infection.
    Wang X; Cai Y; Xing H; Wu W; Wang G; Li L; Chen J
    BMC Microbiol; 2016 Jun; 16(1):124. PubMed ID: 27341798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synergistic activity of sub-inhibitory concentrations of curcumin with ceftazidime and ciprofloxacin against Pseudomonas aeruginosa quorum sensing related genes and virulence traits.
    Roudashti S; Zeighami H; Mirshahabi H; Bahari S; Soltani A; Haghi F
    World J Microbiol Biotechnol; 2017 Mar; 33(3):50. PubMed ID: 28188589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of antibiotic efficacy against infections caused by planktonic or biofilm cultures of Pseudomonas aeruginosa and Klebsiella pneumoniae in Galleria mellonella.
    Benthall G; Touzel RE; Hind CK; Titball RW; Sutton JM; Thomas RJ; Wand ME
    Int J Antimicrob Agents; 2015 Nov; 46(5):538-45. PubMed ID: 26364845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-biofilm and resistance suppression activities of CXA-101 against chronic respiratory infection phenotypes of Pseudomonas aeruginosa strain PAO1.
    Riera E; Macià MD; Mena A; Mulet X; Pérez JL; Ge Y; Oliver A
    J Antimicrob Chemother; 2010 Jul; 65(7):1399-404. PubMed ID: 20435779
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of combined treatment with ambroxol and ciprofloxacin on catheter-associated Pseudomonas aeruginosa biofilms in a rat model.
    Lu Q; Yu J; Bao L; Ran T; Zhong H
    Chemotherapy; 2013; 59(1):51-6. PubMed ID: 23816803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and potential for resistance selection of antipseudomonal treatments in a mouse model of lung infection by hypermutable Pseudomonas aeruginosa.
    Maciá MD; Borrell N; Segura M; Gómez C; Pérez JL; Oliver A
    Antimicrob Agents Chemother; 2006 Mar; 50(3):975-83. PubMed ID: 16495260
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition and destruction of Pseudomonas aeruginosa biofilms by antibiotics and antimicrobial peptides.
    Dosler S; Karaaslan E
    Peptides; 2014 Dec; 62():32-7. PubMed ID: 25285879
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incorporation of Farnesol Significantly Increases the Efficacy of Liposomal Ciprofloxacin against Pseudomonas aeruginosa Biofilms in Vitro.
    Bandara HM; Herpin MJ; Kolacny D; Harb A; Romanovicz D; Smyth HD
    Mol Pharm; 2016 Aug; 13(8):2760-70. PubMed ID: 27383205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular basis of azithromycin-resistant Pseudomonas aeruginosa biofilms.
    Gillis RJ; White KG; Choi KH; Wagner VE; Schweizer HP; Iglewski BH
    Antimicrob Agents Chemother; 2005 Sep; 49(9):3858-67. PubMed ID: 16127063
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Real-Time Monitoring of
    Zaborskyte G; Andersen JB; Kragh KN; Ciofu O
    Antimicrob Agents Chemother; 2017 Mar; 61(3):. PubMed ID: 27993856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 47.